Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study

INTRODUCTION: Remdesivir is a registered treatment for hospitalised patients with COVID-19 that has moderate clinical effectiveness. Anecdotally, some patients’ respiratory insufficiency seemed to recover particularly rapidly after initiation of remdesivir. In this study, we investigated if this rap...

Descripción completa

Detalles Bibliográficos
Autores principales: Leegwater, Emiel, Dol, Lisa, Benard, Menno R., Roelofsen, Eveline E., Delfos, Nathalie M., van der Feltz, Machteld, Mollema, Femke P. N., Bosma, Liesbeth B. E., Visser, Loes E., Ottens, Thomas H., van Burgel, Nathalie D., Arbous, Sesmu M., El Bouazzaoui, Lahssan H., Knevel, Rachel, Groenwold, Rolf H. H., de Boer, Mark G. J., Visser, Leo G., Rosendaal, Frits R., Wilms, Erik B., van Nieuwkoop, Cees
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600071/
https://www.ncbi.nlm.nih.gov/pubmed/37801280
http://dx.doi.org/10.1007/s40121-023-00874-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600071/
https://www.ncbi.nlm.nih.gov/pubmed/37801280
http://dx.doi.org/10.1007/s40121-023-00874-2

Ejemplares similares